A cost-based-plus pricing approach for repurposed tiratricol in the treatment of Allan-Herndon-Dudley syndrome
- DOI
- 10.1186/s13023-026-04269-7
- Published
- 2026-03-05
- Container
- Orphanet Journal of Rare Diseases
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13023-026-04269-7,
title = {A cost-based-plus pricing approach for repurposed tiratricol in the treatment of Allan-Herndon-Dudley syndrome},
author = {Evert Manders and Sarai Keestra and Wilbert Bannenberg and Vincent van der Wel and Saco de Visser and Carla Hollak},
year = {2026},
journal = {Orphanet Journal of Rare Diseases},
doi = {10.1186/s13023-026-04269-7},
url = {https://doi.org/10.1186/s13023-026-04269-7}
}RIS
TY - JOUR TI - A cost-based-plus pricing approach for repurposed tiratricol in the treatment of Allan-Herndon-Dudley syndrome AU - Evert Manders AU - Sarai Keestra AU - Wilbert Bannenberg AU - Vincent van der Wel AU - Saco de Visser AU - Carla Hollak PY - 2026 JO - Orphanet Journal of Rare Diseases DO - 10.1186/s13023-026-04269-7 UR - https://doi.org/10.1186/s13023-026-04269-7 ER -
APA
Manders, E., Keestra, S., Bannenberg, W., Wel, V. V. D., Visser, S. D., & Hollak, C. (2026). A cost-based-plus pricing approach for repurposed tiratricol in the treatment of Allan-Herndon-Dudley syndrome. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/s13023-026-04269-7
Source records
- crossref · retrieved 2026-09-26T09:06:19.775Z